Neurologic sequelae can be devastating complications of respiratory viral infections. We
report the presence of virus in neural and capillary endothelial cells in frontal lobe tissue …

The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …

The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was initially identified in November 2021 in South Africa and Botswana, as well as in …

SARS-CoV-2 lineages have diverged into highly prevalent variants termed "variants of
concern" (VOCs). Here, we characterized emerging SARS-CoV-2 spike polymorphisms in vitro …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

New York City (NYC) has emerged as one of the epicenters of the current severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …

Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…

In December 2019, the 2019, a novel coronavirus disease (COVID‐19) caused by severe
acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) first emerged in Wuhan, China. This …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first
detected in China and has since caused a pandemic of coronavirus disease 2019 (COVID-19). …

Background Monkeypox virus has recently infected more than 88 000 people, raising concerns
about our preparedness against this emerging viral pathogen. Licensed and approved …